Literature DB >> 8139453

Measurement of regional blood oxygenation and cerebral hemodynamics.

B E Hoppel1, R M Weisskoff, K R Thulborn, J B Moore, K K Kwong, B R Rosen.   

Abstract

An echo planar linewidth mapping technique, Shufflebutt, has allowed temporal measurements of changes in linewidth caused by static inhomogeneities (delta LWSI) and transverse relaxation rate (delta R2) in models of hypoxia and hypercapnia. We demonstrate these changes are due to intravascular susceptibility differences/(delta chi) between the blood and tissue. Contrast agent injections at a delta chi equivalent to that of deoxygenated blood showed a twofold difference between the contrast agent and physiological anoxia values. Hypercapnia decreased both delta LWSI and delta R2 consistent with an increase in blood oxygenation. We attribute these findings to constant oxygen extraction during an increase in blood flow, resulting in less deoxygenated venous blood and thus reduced delta chi. For in vivo perturbations we found that delta R2/delta R2' approximately 0.33, a ratio much different from that measured in whole blood phantoms (delta R2/delta R2' approximately 2). This demonstrates that signal changes in these studies are produced predominantly by dephasing of extravascular protons due to field inhomogeneities produced by intravascular deoxygenated hemoglobin (deoxyHb).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8139453     DOI: 10.1002/mrm.1910300609

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  17 in total

1.  Improving high-resolution MR bold venographic imaging using a T1 reducing contrast agent.

Authors:  W Lin; P Mukherjee; H An; Y Yu; Y Wang; K Vo; B Lee; D Kido; E M Haacke
Journal:  J Magn Reson Imaging       Date:  1999-08       Impact factor: 4.813

Review 2.  Functional magnetic resonance imaging: clinical applications and potential.

Authors:  P M Matthews; S Clare; J Adcock
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

3.  Quantitative measurements of cerebral blood oxygen saturation using magnetic resonance imaging.

Authors:  H An; W Lin
Journal:  J Cereb Blood Flow Metab       Date:  2000-08       Impact factor: 6.200

4.  T2 and T2* measurements of fetal brain oxygenation during hypoxia with MRI at 3T: correlation with fetal arterial blood oxygen saturation.

Authors:  Ulrike Wedegärtner; Hendrik Kooijman; Thomas Andreas; Nicola Beindorff; Kurt Hecher; Gerhard Adam
Journal:  Eur Radiol       Date:  2009-07-18       Impact factor: 5.315

5.  Assessment of myocardial oxygenation with MRI.

Authors:  Jie Zheng
Journal:  Quant Imaging Med Surg       Date:  2013-04

Review 6.  Vessel caliber--a potential MRI biomarker of tumour response in clinical trials.

Authors:  Kyrre E Emblem; Christian T Farrar; Elizabeth R Gerstner; Tracy T Batchelor; Ronald J H Borra; Bruce R Rosen; A Gregory Sorensen; Rakesh K Jain
Journal:  Nat Rev Clin Oncol       Date:  2014-08-12       Impact factor: 66.675

7.  Photoacoustic imaging of vascular hemodynamics: validation with blood oxygenation level-dependent MR imaging.

Authors:  Laurie J Rich; Mukund Seshadri
Journal:  Radiology       Date:  2014-11-20       Impact factor: 11.105

8.  GESFIDE-PROPELLER approach for simultaneous R2 and R2* measurements in the abdomen.

Authors:  Ning Jin; Yang Guo; Zhuoli Zhang; Longjiang Zhang; Guangming Lu; Andrew C Larson
Journal:  Magn Reson Imaging       Date:  2013-09-14       Impact factor: 2.546

Review 9.  Blood oxygenation level-dependent (BOLD)-based techniques for the quantification of brain hemodynamic and metabolic properties - theoretical models and experimental approaches.

Authors:  Dmitriy A Yablonskiy; Alexander L Sukstanskii; Xiang He
Journal:  NMR Biomed       Date:  2012-08-28       Impact factor: 4.044

10.  Regional brain changes in bipolar I depression: a functional magnetic resonance imaging study.

Authors:  Lori Altshuler; Susan Bookheimer; Jennifer Townsend; Manuel A Proenza; Fred Sabb; Jim Mintz; Mark S Cohen
Journal:  Bipolar Disord       Date:  2008-09       Impact factor: 6.744

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.